Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Neurogene (NGNE) Accumulated Depreciation & Amortization (2018 - 2025)

Neurogene's Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 4.91% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, down 4.91%, while the annual FY2025 figure was $3.0 million, 4.91% down from the prior year.
  • Accumulated Depreciation & Amortization reached $3.0 million in Q4 2025 per NGNE's latest filing, up from $2.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.3 million in Q4 2023 to a low of $700000.0 in Q1 2025.
  • Average Accumulated Depreciation & Amortization over 3 years is $1.6 million, with a median of $807000.0 recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 67.28% in 2024, then surged 183.38% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $3.3 million in 2023, then decreased by 3.03% to $3.2 million in 2024, then dropped by 4.91% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Accumulated Depreciation & Amortization are $3.0 million (Q4 2025), $2.3 million (Q3 2025), and $800000.0 (Q2 2025).